Insmed Inc [INSM] stock prices are down -0.33% to $72.51 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The INSM shares have gain 11.13% over the last week, with a monthly amount drifted -1.20%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Insmed Inc [NASDAQ: INSM] stock has seen the most recent analyst activity on April 23, 2024, when Truist initiated its Buy rating and assigned the stock a price target of $48. Previously, Wolfe Research started tracking the stock with Outperform rating on February 15, 2024, and set its price target to $42. On December 08, 2023, Wells Fargo initiated with a Overweight rating and assigned a price target of $55 on the stock. Guggenheim initiated its recommendation with a Buy and recommended $50 as its price target on July 26, 2023. Mizuho started tracking with a Buy rating for this stock on December 09, 2022, and assigned it a price target of $28. In a note dated December 07, 2022, Barclays initiated an Overweight rating and provided a target price of $37 on this stock.
The stock price of Insmed Inc [INSM] has been fluctuating between $21.92 and $80.53 over the past year. Currently, Wall Street analysts expect the stock to reach $88.5 within the next 12 months. Insmed Inc [NASDAQ: INSM] shares were valued at $72.51 at the most recent close of the market. An investor can expect a potential return of 22.05% based on the average INSM price forecast.
Analyzing the INSM fundamentals
The Insmed Inc [NASDAQ:INSM] reported sales of 342.96M for trailing twelve months, representing a surge of 18.15%. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at -2.14%, Pretax Profit Margin comes in at -2.51%, and Net Profit Margin reading is -2.52%. To continue investigating profitability, this company’s Return on Assets is posted at -0.42, Equity is 12.59 and Total Capital is -0.41. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of2.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 71.47 points at the first support level, and at 70.42 for the second support level. However, for the 1st resistance point, the stock is sitting at 73.59, and for the 2nd resistance point, it is at 74.67.
Ratios To Look Out For
It’s worth pointing out that Insmed Inc [NASDAQ:INSM]’s Current Ratio is 6.37. On the other hand, the Quick Ratio is 5.99, and the Cash Ratio is 1.78. Considering the valuation of this stock, the price to sales ratio is 37.82, the price to book ratio is 26.83.
Transactions by insiders
Recent insider trading involved Flammer Martina M.D., Chief Medical Officer, that happened on Jan 14 ’25 when 1384.0 shares were sold. Chief Operating Officer, Adsett Roger completed a deal on Jan 14 ’25 to sell 1457.0 shares. Meanwhile, Chief People Strategy Officer Schaeffer Orlov S Nicole sold 872.0 shares on Jan 14 ’25.
